Literature DB >> 10948182

Random transposon mutagenesis of Campylobacter jejuni.

N J Golden1, A Camilli, D W Acheson.   

Abstract

Genetic studies of Campylobacter jejuni have been limited due to the lack of a transposon mutagenesis method. Here, we describe a novel technique for random transposon mutagenesis using a mariner-based transposon into C. jejuni strain 480. Insertions were random, as demonstrated by Southern blot analysis and insertional junction sequencing. We have demonstrated, for the first time, random in vivo transposon mutagenesis of C. jejuni.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10948182      PMCID: PMC101816          DOI: 10.1128/IAI.68.9.5450-5453.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Systematic identification of essential genes by in vitro mariner mutagenesis.

Authors:  B J Akerley; E J Rubin; A Camilli; D J Lampe; H M Robertson; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

2.  The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences.

Authors:  J Parkhill; B W Wren; K Mungall; J M Ketley; C Churcher; D Basham; T Chillingworth; R M Davies; T Feltwell; S Holroyd; K Jagels; A V Karlyshev; S Moule; M J Pallen; C W Penn; M A Quail; M A Rajandream; K M Rutherford; A H van Vliet; S Whitehead; B G Barrell
Journal:  Nature       Date:  2000-02-10       Impact factor: 49.962

3.  Hyperactive transposase mutants of the Himar1 mariner transposon.

Authors:  D J Lampe; B J Akerley; E J Rubin; J J Mekalanos; H M Robertson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

4.  Flagellin expression in Campylobacter jejuni is regulated at the transcriptional level.

Authors:  P J Nuijten; N M Bleumink-Pluym; W Gaastra; B A van der Zeijst
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

5.  A purified mariner transposase is sufficient to mediate transposition in vitro.

Authors:  D J Lampe; M E Churchill; H M Robertson
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

6.  Identification of Campylobacter jejuni promoter sequences.

Authors:  M M Wösten; M Boeve; M G Koot; A C van Nuenen; B A van der Zeijst
Journal:  J Bacteriol       Date:  1998-02       Impact factor: 3.490

7.  Genetic manipulation of Campylobacter: evaluation of natural transformation and electro-transformation.

Authors:  T M Wassenaar; B N Fry; B A van der Zeijst
Journal:  Gene       Date:  1993-09-30       Impact factor: 3.688

8.  Construction of new Campylobacter cloning vectors and a new mutational cat cassette.

Authors:  R Yao; R A Alm; T J Trust; P Guerry
Journal:  Gene       Date:  1993-08-16       Impact factor: 3.688

9.  Cloning of Campylobacter jejuni genes required for leucine biosynthesis, and construction of leu-negative mutant of C. jejuni by shuttle transposon mutagenesis.

Authors:  A Labigne; P Courcoux; L Tompkins
Journal:  Res Microbiol       Date:  1992-01       Impact factor: 3.992

10.  Gene disruption and replacement as a feasible approach for mutagenesis of Campylobacter jejuni.

Authors:  A Labigne-Roussel; P Courcoux; L Tompkins
Journal:  J Bacteriol       Date:  1988-04       Impact factor: 3.490

View more
  10 in total

1.  Development of a mariner-based transposon for use in Sorangium cellulosum.

Authors:  Bryan Julien; Ruby Fehd
Journal:  Appl Environ Microbiol       Date:  2003-10       Impact factor: 4.792

2.  In vitro transposition system for efficient generation of random mutants of Campylobacter jejuni.

Authors:  O R Colegio; T J Griffin; N D Grindley; J E Galán
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

3.  CdtA, CdtB, and CdtC form a tripartite complex that is required for cytolethal distending toxin activity.

Authors:  M Lara-Tejero; J E Galán
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  Identification of motility and autoagglutination Campylobacter jejuni mutants by random transposon mutagenesis.

Authors:  Neal J Golden; David W K Acheson
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

5.  Campylobacter jejuni biofilms up-regulated in the absence of the stringent response utilize a calcofluor white-reactive polysaccharide.

Authors:  Meghan K McLennan; Danielle D Ringoir; Emilisa Frirdich; Sarah L Svensson; Derek H Wells; Harold Jarrell; Christine M Szymanski; Erin C Gaynor
Journal:  J Bacteriol       Date:  2007-11-09       Impact factor: 3.490

6.  Genetic manipulation of Campylobacter jejuni.

Authors:  Lindsay Davis; Kathryn Young; Victor DiRita
Journal:  Curr Protoc Microbiol       Date:  2008-08

Review 7.  New molecular microbiology approaches in the study of Campylobacter fetus.

Authors:  Sabine Kienesberger; Gregor Gorkiewicz; Heimo Wolinski; Ellen L Zechner
Journal:  Microb Biotechnol       Date:  2011-01       Impact factor: 5.813

8.  Hygromycin B and apramycin antibiotic resistance cassettes for use in Campylobacter jejuni.

Authors:  Andrew Cameron; Erin C Gaynor
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

9.  The protein network of bacterial motility.

Authors:  Seesandra V Rajagopala; Björn Titz; Johannes Goll; Jodi R Parrish; Katrin Wohlbold; Matthew T McKevitt; Timothy Palzkill; Hirotada Mori; Russell L Finley; Peter Uetz
Journal:  Mol Syst Biol       Date:  2007-07-31       Impact factor: 11.429

10.  Development of a novel system for isolating genes involved in predator-prey interactions using host independent derivatives of Bdellovibrio bacteriovorus 109J.

Authors:  Adrian A Medina; Robert M Shanks; Daniel E Kadouri
Journal:  BMC Microbiol       Date:  2008-02-19       Impact factor: 3.605

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.